
Reset all filters
01 2Merck Canada Inc.
Reset all filters
01 22549062
Reset all filters
01 2TEDIZOLID PHOSPHATE
Reset all filters
01 1POWDER FOR SOLUTION
02 1TABLET
Reset all filters
01 22024-12-17
Patent Expiration Date : 2024-12-17
Date Granted : 2011-07-05
Brand Name : SIVEXTRO?
Patent Number : 2549062
Filing Date : 2004-12-17
Strength per Unit : 200mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-12-17
Date Granted : 2011-07-05
Patent Expiration Date : 2024-12-17
Date Granted : 2011-07-05
Brand Name : SIVEXTRO?
Patent Number : 2549062
Filing Date : 2004-12-17
Strength per Unit : 200mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2024-12-17
Date Granted : 2011-07-05